Clinical Trial Update: PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics and safety study of 90-day use of vaginal rings containing dapivirine and levonorgestrel has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dapivirine vaginal ring (dapivirine)
• Levonorgestrel vaginal ring (levonorgestrel)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: Pharmacokinetics, Safety Issues | Phase 1 | Status: COMPLETED